Abstract:Since the first genome-wide association study on human age-related macular degeneration was reported by Science journal in 2005, a series of genome-wide association studies have been published on human complex diseases or traits, such as obesity, type 2 diabetes, coronary artery disease, Alzheimer's disease and so on. The study of human genetics has recently undergone a dramatic transition which is called "the first wave of genome-wide association study". Some issues in statistical analysis of genome-wide association studies were reviewed by this paper. First, statistical analysis guidelines, methods and examples for genome-wide association studies of different designs, including unrelated case-control studies, population-based studies, and family-based association studies; second, multiple testing correction of P values, including Bonferroni correction, step-down Bonferroni correction, permutation correction, and the correction based on false discovery rate; third, population stratification and its effect on inference of genotype-phenotype associations. The False Positive Re-port Probability has been successfully applied in a recent genome-wide association study on coronary artery disease to con-trol the population stratification. Although genetic statistical methodology has been greatly developed in control of false positive associations caused by multiple testing or population stratification, it is still not sufficient to achieve the goal. Replicating genotype-phenotype associations is the only way to identify true association between genetic markers and common disease traits. The first wave of genome-wide association studies is producing an impressive list of unexpected associations between genes or chromosomal regions and a broad range of diseases. Traditional statistical techniques are adequate for the analysis and interpretation of these results. However, much more sophisticated methods of statistical analysis are likely to be required as we delve further into the genome in the search for networks of interacting gene variants, or interactions be-tween gene-gene networks and environmental factors. Finally, some useful links about statistical software for genome-wide association studies were provided.

[The Application of Genetic Risk Score in Genetic Studies of Complex Human Diseases].

Genetic Risk Score: Principle, Methods and Application

Evaluating the predictive value of genetic risk score in colorectal cancer among Chinese Han population

Application of Genomewide Association Studies in Complex Human Disease

Genetic risk prediction in complex disease

Polygenic scores and their applications in kidney disease

PCA-based GRS Analysis Enhances the Effectiveness for Genetic Correlation Detection.

Genetic Risk Scores to Predict the Prognosis of Chronic Heart Failure Patients in Chinese Han.

Genomic Prediction of Complex Disease Risk

Genetic Risk Score Increased Discriminant Efficiency of Predictive Models for Type 2 Diabetes Mellitus Using Machine Learning: Cohort Study.

Genetic Risk Scores for the Clinical Rheumatologist

Genome-wide polygenic scores for common diseases identify individuals with risk equivalent to monogenic mutations

Polygenic risk scores: from research tools to clinical instruments

Systems biology approaches to utilise polygenic risk scores for chronic diseases

Simulating genetic risk scores from summary statistics

Genome-wide association study on complex diseases: genetic statistical issues]

DeepRisk: A deep learning approach for genome-wide assessment of common disease risk

Genetic determinants of gestational diabetes mellitus: a case–control study in two independent populations

A comprehensive investigation of statistical and machine learning approaches for predicting complex human diseases on genomic variants

Genomic Prediction of 16 Complex Disease Risks Including Heart Attack, Diabetes, Breast and Prostate Cancer

Genomewide Association Study: Advances, Challenges and Deliberation